Tetrous, Inc. is a regenerative medicine company guided by a team of influential surgeons and regenerative medicine scientists, and led by experienced medical device executives. It utilizes next generation advanced technologies for enthesis repair in sports medicine applications, with its first product directed at improving enthesis repair in rotator cuff surgeries. Founded in 2019, the firm is headquartered in Los Angeles, CA with service operations in Chicago, IL and a laboratory in Mammoth Lakes, CA. The demineralized bone fiber technology used in Tetrous’ products is licensed exclusively for use in sports medicine from TheraCell, Inc., an Isto Biologics company.